Clinical Trial Update: Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Flu-Bu-Mel based conditioning regimen for patients with lymphoid malignancies undergoing allogeneic hematopoietic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Neoplasm

Drugs mentioned

• Flu-Bu-Mel Based Conditioning Regimen

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Lymphoid Neoplasm | Phase 2 | Status: UNKNOWN